Skip to Main Content

Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma (NAVIGATOR)

Conditions

Asthma | Men's Health | Women's Health

Phase III

What is the purpose of this trial?

Brief Summary:

A Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults and Adolescents with Severe Uncontrolled Asthma

  • Trial with
    Astra Zeneca
  • Start Date
    08/24/2018
  • End Date
    09/17/2020
Trial Image

For more information about this study, contact:

Terri-Dawn Levesh

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    09/12/2018
  • Study HIC
    #2000023821